This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: INSPIRE Trial - Nivolumab and Ipilimumab in Molecularly Selected mCRPC Patients

116 views
October 1, 2024
Comments 0
Login to view comments. Click here to Login